Explore the Global Arteriovenous Fistula Treatment Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Arteriovenous Fistula Treatment Market

Key Insight

Arteriovenous fistulas represent 68.2% of fistula types sales and transcatheter embolization accounts for 56.3% within the treatment type segment in 2026. The arteriovenous fistula treatment market was valued at USD 868.8 million in 2025, is projected to reach USD 1.63 billion by 2036 and is forecast to post a 5.9% CAGR between 2026 and 2036.

May 08, 2026

Anurag Sharma

342 Pages

Cite this Report

Arteriovenous Fistula Treatment Market

https://www.futuremarketinsights.com/reports/arteriovenous-fistula-treatment-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

B BRAUN MELSUNGEN AG RDI project
Becton Dickinson
Cook Group
Fresenius Medical Care AG & Co. KGaA
Mayo Clinic
Medtronic plc
NxStage Medical Inc
Poly Medicure Limited
Proteon Therapeutics
Shire plc
Teleflex Incorporated

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Arteriovenous Fistula Treatment Market

Key Players

Similar Industry Reports